Lifestyle
- Regular physical activity
- Stress management
- Adequate sleep
Mean Platelet Volume · Mittleres Plättchenvolumen
Mean Platelet Volume quantifies the average size of platelets in the blood.
Reference ranges may vary slightly based on laboratory standards and population demographics.
Mean Platelet Volume (MPV) is a hematological parameter that measures the average size of platelets in the blood. It is calculated using automated blood analyzers and reflects the platelet production rate and activation. Larger platelets are generally younger and more active, which can be indicative of various physiological and pathological processes. Clinically, MPV is considered a marker of platelet function and is associated with several conditions. Elevated MPV levels have been linked to cardiovascular diseases, diabetes mellitus, and certain autoimmune disorders, where it may reflect increased platelet activation and turnover. Conversely, low MPV levels have been observed in conditions like acute appendicitis and certain inflammatory states. In the context of athletic performance, biohacking, or longevity, MPV can provide insights into systemic inflammation and overall cardiovascular health, which are critical factors for optimizing physical performance and longevity. However, the interpretation of MPV should be approached with caution due to potential confounding factors such as ethnicity, age, and underlying health conditions. Additionally, standardization of cutoff values is necessary for consistent clinical application, as variations in laboratory techniques and population demographics can affect results.
Klinische Bedeutung
Elevated MPV values may indicate increased platelet activation, often seen in cardiovascular diseases, diabetes, and autoimmune disorders. Reduced MPV values can be associated with acute inflammatory conditions like appendicitis.
Progressively rising MPV values may suggest worsening inflammation or increased cardiovascular risk. Re-test in 4-6 weeks if clinically indicated.
Progressively falling MPV values could indicate resolution of inflammation or effective treatment of underlying conditions.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant lifestyle or dietary changes.
MPV may vary slightly throughout the day; consistent timing for tests is recommended.
Testing Frequency
Annually for routine health check-ups, more frequently if monitoring specific conditions.
Current research suggests that there is a need for standardization of reference ranges and optimal cutoff values for mean platelet volume (MPV) across different populations and conditions, particularly in autoimmune disorders and preeclampsia. Researchers have not yet established the specific confounders affecting MPV measurements, such as ethnicity and disease severity. Additionally, clinical questions remain unanswered regarding the predictive value of MPV in various inflammatory conditions and its role in disease monitoring.
869
Total Citations
15
Human/RCT
2.8
Avg. Influence
2026
Latest
Korniluk Aleksandra, et al. · Mediators of inflammation · 2019
Researchers reviewed literature on mean platelet volume (MPV) as a biomarker in inflammatory and neoplastic diseases. They found that increased MPV is associated with various conditions, including cardiovascular diseases and cancers, while decreased MPV is noted in certain inflammatory states. The study emphasizes the potential of MPV in predicting disease progression and outcomes.
Key findings
This review focused on the potential of mean platelet volume (MPV) and immature platelet fraction (IPF) as biomarkers in autoimmune disorders. Researchers highlighted the need for standardization of cutoff values for both MPV and IPF, as current data on their utility in autoimmune conditions remain scarce and controversial.
This review discussed the role of mean platelet volume (MPV) as a biomarker for heart disease risk and prognosis. Researchers noted that MPV may predict ischemic stroke risk in atrial fibrillation patients and guide treatment decisions in coronary artery disease.
This study examined the role of platelet function markers in preeclampsia, focusing on mean platelet volume (MPV). Researchers found that women with preeclampsia had significantly higher MPV compared to those without the condition, suggesting MPV as a promising biomarker for evaluating platelet function in preeclampsia.
Researchers explored the prognostic value of platelet indices in patients with sepsis. They found that non-survivors had significantly higher changes in mean platelet volume (MPV) and platelet distribution width (PDW) compared to survivors. MPV and PDW at admission were identified as independent predictors of mortality in sepsis patients.
This meta-analysis evaluated mean platelet volume (MPV) differences in preeclampsia patients compared to healthy women. Researchers found that MPV was significantly higher in preeclamptic women, particularly in severe cases, indicating its potential as a biomarker for detecting and monitoring preeclampsia.
This study explored the role of mean platelet volume (MPV) in patients with tuberculosis and diabetes mellitus. Researchers found that MPV was significantly lower in patients with both conditions compared to those with either disease alone, suggesting its potential as a diagnostic marker.
This study investigated the association of mean platelet volume (MPV) with renal cell carcinoma (RCC). Researchers found that RCC patients had significantly lower MPV compared to those with benign tumors and healthy controls, suggesting MPV could be a useful risk assessment tool.
This meta-analysis investigated the relationship between mean platelet volume (MPV) and acute appendicitis (AA). Researchers found that MPV levels were significantly lower in patients with AA compared to controls, suggesting MPV could serve as a potential biomarker for this condition.
This study explored the relationship between mean platelet volume (MPV) and resistant hypertension (RH). Researchers found that MPV was significantly higher in patients with RH compared to those with controlled hypertension and normotensive individuals, suggesting it may indicate cardiovascular risk in these patients.
6
Total Trials
702
Total Enrolled
Assiut University
200
2026
Mean Platelet Volume (MPV)
Esraa Hamdy Thabit Riad
80
2025
HBP levels in survivors and non survivors patients of VAP measured by ng\ ml using ElISAImmunoassay
Sohag University
100
2024
Evaluate the hematological indices as (mean platelet volume) of our SLE patient.
Cairo University
80
2020
Salivary c reactive protein in neonatal sepsis
Rania Hassan Mostafa
140
2019
Mean Platelet Volume (MPV)
Isfahan University of Medical Sciences
102
2016
MPV in patients and controls
Research publications about MPV over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer